Wird geladen...
Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing
PURPOSE OF REVIEW: Clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated 9 (Cas9) has recently emerged as a top genome editing technology and has afforded investigators the ability to more easily study a number of diseases. This review discusses CRISPR/Cas9’s advantages...
Gespeichert in:
| Veröffentlicht in: | Curr Atheroscler Rep |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5832020/ https://ncbi.nlm.nih.gov/pubmed/28550381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11883-017-0668-8 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|